Atlas Trials

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

Clinical trial NCT03786575 · UNKNOWN

Trial details

NCT number
NCT03786575
Sponsor
Peking Union Medical College
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Neoplasm FemaleTherapeuticsMutation
Start date
2018-12-01
Primary completion
2021-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.